Drug-eluting stents in diabetic patients: Are we still treading water?

Mauro Chiarito, Roxana Mehran

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Diabetic patients are frequently affected by coronary artery disease (CAD) and are at increased risk of CAD-related adverse events, even after drug-eluting stent (DES) implantation. If currently available DES have similar safety and efficacy in diabetic and nondiabetic patients is still debated. This prospective, multicenter registry showed similar 3-year outcome in patients undergoing different DES implantation, although diabetic patients, especially those requiring insulin treatment, had significantly higher risk of adverse events than nondiabetic patients. Specific efforts to improve the performance of DES in diabetic patients are mandatory to adequately address the unsolved issue of diabetic patients affected by CAD.

Original languageEnglish
Pages (from-to)253-254
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume96
Issue number2
DOIs
StatePublished - 1 Aug 2020

Fingerprint

Dive into the research topics of 'Drug-eluting stents in diabetic patients: Are we still treading water?'. Together they form a unique fingerprint.

Cite this